West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 218.58 USD 3.38% Market Closed
Market Cap: 15.7B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one WST stock under the Base Case scenario is 281.01 USD. Compared to the current market price of 218.58 USD, West Pharmaceutical Services Inc is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

WST Relative Value
Base Case
281.01 USD
Undervaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.4
P/S
P/S
Price to Sales
5.4
vs History
95
vs Industry
33
Median 3Y
8.1
Median 5Y
8.9
Industry
3.7
Forward
5.2
More Details
33.6
P/E
P/E
Price to Earnings
33.6
vs History
84
vs Industry
20
Median 3Y
43.3
Median 5Y
46.6
Industry
30.1
Forward
34.4
More Details
23.6
P/OCF
P/OCF
Price to OCF
23.6
vs History
95
vs Industry
21
Median 3Y
33.2
Median 5Y
36.2
Industry
18.7
More Details
56.1
P/FCFE
P/FCFE
Price to FCFE
56.1
vs History
80
vs Industry
9
Median 3Y
64.6
Median 5Y
68.3
Industry
32
More Details
5.8
P/B
P/B
Price to Book Value
5.8
vs History
95
vs Industry
15
Median 3Y
9
Median 5Y
9.8
Industry
2.4
More Details
5.4
EV/S
EV/S
Enterprise Value to Sales
5.4
vs History
95
vs Industry
31
Median 3Y
7.9
Median 5Y
8.6
Industry
3.4
Forward
5.2
More Details
15.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
15.5
vs History
88
vs Industry
21
Median 3Y
21.7
Median 5Y
23.4
Industry
8.1
More Details
20.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.8
vs History
88
vs Industry
20
Median 3Y
29.1
Median 5Y
31.7
Industry
16.7
Forward
21.4
More Details
26.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
26.5
vs History
87
vs Industry
20
Median 3Y
35.5
Median 5Y
38.6
Industry
22.2
Forward
28
More Details
23.3
EV/OCF
EV/OCF
Enterprise Value to OCF
23.3
vs History
93
vs Industry
23
Median 3Y
32.2
Median 5Y
35.8
Industry
17.7
More Details
50.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
50.5
vs History
87
vs Industry
11
Median 3Y
60.4
Median 5Y
65.6
Industry
22.6
More Details
5.2
EV/IC
EV/IC
Enterprise Value to IC
5.2
vs History
95
vs Industry
17
Median 3Y
8.7
Median 5Y
9.6
Industry
2.2
More Details

Multiples Across Competitors

WST Competitors Multiples
West Pharmaceutical Services Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
West Pharmaceutical Services Inc
NYSE:WST
15.7B USD 5.4 33.6 20.8 26.5
US
PerkinElmer Inc
LSE:0KHE
1T USD 364.7 3 524.6 1 235.9 2 520.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
150.4B USD 3.5 23.1 16.3 22.4
US
Danaher Corp
NYSE:DHR
137.5B USD 5.8 36.5 20.1 29.4
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW 14.5 55.6 32.3 44.9
CH
Lonza Group AG
SIX:LONN
39.2B CHF 6 61.7 22.6 35.3
US
Agilent Technologies Inc
NYSE:A
32.4B USD 4.9 27.7 18.8 22.2
CN
WuXi AppTec Co Ltd
SSE:603259
186.2B CNY 4.6 16.7 15.9 15.9
US
IQVIA Holdings Inc
NYSE:IQV
25.7B USD 1.7 19.2 10.9 16.2
US
Mettler-Toledo International Inc
NYSE:MTD
24.2B USD 6.3 28.5 21.2 23.6
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.9B EUR 6.6 92.3 29.5 52.2

See Also

Summary
WST intrinsic value, competitors valuation, and company profile.
DCF Valuation
WST stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WST stock valuation using valuation multiples.
Wall Street Estimates
WST price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WST stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 259,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.